Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
Jing‐Quan Wang, Yuqi Yang, Chao‐Yun Cai, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100743-100743
Closed Access | Times Cited: 177

Showing 26-50 of 177 citing articles:

Nanomaterials as an advanced nano-tool for the Doxorubicin delivery/ Co-Delivery—A Comprehensive Review
Rabia Arshad, Muhammad Salman Arshad, Abbas Rahdar, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 83, pp. 104432-104432
Closed Access | Times Cited: 28
Overcoming Cancer Resistance to Platinum Drugs by Inhibiting Cholesterol Metabolism
Ying Wang, Linxiang Cai, Hui Li, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Closed Access | Times Cited: 27
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
D Chen, Yuhao Xie, Lu-Qi Cao, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101062-101062
Closed Access | Times Cited: 10
The role of lncRNA NEAT1 in human cancer chemoresistance
Feng Long, Xue Li, Jingyu Pan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Structural View of Cryo-Electron Microscopy-Determined ATP-Binding Cassette Transporters in Human Multidrug Resistance
Wenjie Fan, Kai Shao, Min Luo
Biomolecules (2024) Vol. 14, Iss. 2, pp. 231-231
Open Access | Times Cited: 9
Emerging Strategies to Overcome Chemoresistance: Structural Insights and Therapeutic Targeting of Multidrug Resistance-Linked ATP-Binding Cassette Transporters
Raghavendra Sashi Krishna Nagampalli, Gangadhar P. Vadla, Eswar Kumar Nadendla
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
In vitro biomimetic models for glioblastoma-a promising tool for drug response studies
Tijana Stanković, Teodora Ranđelović, Miodrag Dragoj, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100753-100753
Open Access | Times Cited: 46
Molecular Modeling Strategies of Cancer Multidrug Resistance
Gözde Yalçın
Drug Resistance Updates (2021) Vol. 59, pp. 100789-100789
Closed Access | Times Cited: 46
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
Magdalena Jurczyk, Janusz Kasperczyk, Dorota Wrześniok, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1187-1187
Open Access | Times Cited: 37
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Sihong Chen, Yingxi Zhao, Shougeng Liu, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100821-100821
Closed Access | Times Cited: 34
Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
Kristína Šimoničová, Ľuboš Janotka, Helena Kavcová, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100805-100805
Closed Access | Times Cited: 33
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, et al.
Drug Resistance Updates (2022) Vol. 60, pp. 100811-100811
Open Access | Times Cited: 30
Pentagalloyl Glucose: A Review of Anticancer Properties, Molecular Targets, Mechanisms of Action, Pharmacokinetics, and Safety Profile
Chengli Wen, Nathupakorn Dechsupa, Zehui Yu, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4856-4856
Open Access | Times Cited: 21
Active Ingredients from Chinese Medicine for Combination Cancer Therapy
Xuan Wang, Jing Li, Ruie Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3499-3525
Open Access | Times Cited: 19
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106007-106007
Open Access | Times Cited: 8
The association of ABC proteins with multidrug resistance in cancer
Ana Elisa Zulliani Stroppa Marques, Bruna Estelita Ruginsk, Larissa de Oliveira Prado, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024), pp. 119878-119878
Closed Access | Times Cited: 7
Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells
Xinlin Lin, Mengsi Zheng, Kai Xiong, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 8372-8382
Closed Access | Times Cited: 6
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer
Yiding Wang, Xuejun Gan, Xiaojing Cheng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 6
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy
Anna Choromańska, Agnieszka Chwiłkowska, Julita Kulbacka, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1850-1850
Open Access | Times Cited: 34
Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 811-811
Open Access | Times Cited: 24
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
Sven Marcel Stefan, Patric J. Jansson, Jens Pahnke, et al.
Scientific Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
Bin Du, Mei Zheng, Huizhen Ma, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23

Scroll to top